Reference
Paschke L, et al. Anti VEGF-TKI Treatment and New Renal Adverse Events Not Reported in Phase III Trials. European Thyroid Journal 7: 308-312, No. 6, Nov 2018. Available from: URL: http://doi.org/10.1159/000491387 - Germany
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1733, 238 (2018). https://doi.org/10.1007/s40278-018-56037-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-56037-4